Chicago-based Celegence, which offers regulatory affairs solutions and services for the life sciences sector, has reportedly acquired Dutch pharmaceutical data management firm, Qdossier.
Qdossier offers end-to-end services for managing documents and dossier lifecycle for pharmaceutical products. It also provides cloud-based technology in order to build consistent, transparent, and reusable regulatory dossiers.
Through this deal, Celegence will be able to enhance its wide regulatory consultants network for the pharmaceutical sector by leveraging the additional manpower of regulatory experts from Qdossier. Together, the two will continue advising manufacturers on regulatory requirements and compliance to launch as well as maintain their respective products in the market landscape.
Celegence CEO, Sonia Veluchamy, stated that Qdossier’s technology and regulatory expertise are in line with the services and solutions Celegence offers.
She explained that Celegence works with its clients as trusted advisors to help enhance regulatory compliance efficiency, allowing them to successfully launch new products in the market, and maintain them as well.
Veluchamy further added that by combining the two firm’s expertise, along with technology that supports effective data and document management and compliance, Celegence will be able to provide practical, strategic, and personalized regulatory support to the global pharmaceutical industries.
Apart from offering consultative services, Celegence created an EU Medical Device Regulation (MDR) and In-Vitro Diagnostic Regulation (IVDR) compliance technology called CAPTIS™, which automates medical writing and document maintenance.
It is to be noted that the acquisition has also increased the firm’s scope of technology offerings with the addition of Qdossier’s advanced cloud-based dossier management solution Dossplorer™.
Hans van Bruggen, CEO and Senior Regulatory Affairs Scientist, Qdossier, stated that the partnership with Celegence allows the company to further extend its presence worldwide by offering complementary expertise and technologies.
van Bruggen expressed his delight in joining the Celegence team and working alongside to be able to offer high-level customer services to help clients better comply with regulations and deliver products, while also recording and managing data of their medicinal products.